Infantile neurocysticercosis. About a case
Keywords:
neurocysticercosis, symptomatic epilepsy, seizuresAbstract
Neurocysticercosis is one of the most frequent parasitic infections caused by the larva of Taenia solium when invading the central nervous system. This pathology is endemic to some African countries, and is related to dietary habits, customs, hygiene and socioeconomic factors, with a higher incidence in school patients and adolescents, although it can occur at any age. Its clinical symptoms are variable, linked to epidemiological criteria that make it essential for the attending physician to perform a clinical examination and imaging studies It is presented the clinical case of a 10-year-old girl from Kuito-Bie, Angola, who attended the neurology clinic with vision loss of approximately 6 months of evolution, decreased muscle strength, episodes of hallucinations, incoherent speech, and generalized tonic-clonic seizures of 7 days of evolution. An emergency computed axial tomography of the skull was requested, where active neurocysticercosis is confirmed, with symptomatic epilepsy in its course. Clinical and imaging findings allow timely diagnosis and effective treatment, which determines the clinical evolution of neurocysticercosis in childhood, depending on the clinical stage and the host's immune response.
Downloads
References
2. Cuzco Macías AC, Cuzco Macías LG. Neurocisticercosis. Caso Clínico. AVFT [Internet]. 2021 [citado 05/10/2023];40(7). Disponible en: https://www.redalyc.org/journal/559/55971545004/55971545004.pdf
3. Nunton J. Seroprevalencia y factores asociados a la cisticercosis en estudiantes de la Universidad Nacional de Tumbes. Manglar (Tumbes) [Internet]. 2019 [citado 05/10/2023];16(1):45-51. Disponible en: https://erp.untumbes.edu.pe/revistas/index.php/manglar/article/view/116
4. Salas Contreras R. Neurocisticercosis en la génesis de la epilepsia. PortalesMédicos.com [Internet]. 2021 [citado 05/10/2023];16(8):e418. Disponible en: https://www.revista-portalesmedicos.com/revista-medica/neurocisticercosis-en-la-genesis-de-la-epilepsia/
5. Toquero M, Morocoima A, Ferrer E. Seroprevalencia y factores de riesgo de cisticercosis en dos comunidades rurales del norte del estado Anzoátegui, Venezuela. Biomédica [Internet]. 2017 [citado 05/10/2023];37(Supl.1):66-74. Disponible en: https://revistabiomedica.org/index.php/biomedica/article/view/2841
6. Sáenz C, Velásquez R, Argueta V, et al. Neurocisticercosis: revisión de 5 años en Hospital General de Guatemala. Patología Rev Latinoam [Internet]. 2022 [citado 05/10/2023];60:1-5. Disponible en: https://www.revistapatologia.com/articulo/neurocisticercosis-revision-de-5-anos-en-hospital-general-de-guatemala
7. Campos Duarte K, Vargas Mena R, Hidalgo Azofeifa S. Neurocisticercosis. Rev Médica Sinerg [Internet]. 2021 [citado 05/10/2023];6(11):e729. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/729
8. Sequeda Monterroza JF, Tirado Pérez IS, Zárate Vergara AC. Neurocisticercosis en preescolares: presentación de caso. Rev Cienc Salud. 2016;14(1):123-30. DOI: 10.12804/revsalud14.01.2016.08.
9. López Gulfo DC, Aristizábal Echeverry AM, Flórez Cabezas PK, et al. Caracterización de pacientes con diagnóstico de neurocisticercosis en población pediátrica de Cartagena. Pediatr [Internet]. 2022 [citado 05/10/2023];55(3):120-6. Disponible en: https://revistapediatria.org/rp/article/download/289/223/3270
10. González N, Hawith K, Rodríguez S. Cisticercosis. Reporte de Caso. Act Ped Hond [Internet]. 2017 [citado 05/10/2023];8(1). Disponible en: http://www.bvs.hn/APH/pdf/APHVol8/pdf/APHVol8-1-2017-7.pdf
11. Lafuente González AP, Roldán Pinargote FE, Soto Silva GA, et al. Neurocisticercosis, diagnóstico y tratamiento. Recimundo. 2022;6(3):136-46. DOI: 10.26820/recimundo/6.(3).junio.2022.136-146.
12. Velasquez Salazar R, Rojas S, Briceño A, et al. Neurocisticercosis: enfermedad infecciosa desatendida, olvidada y emergente. A propósito de un caso. Comunidad y Salud [Internet]. 2016 [citado 05/10/2023];14(2):14-23. Disponible en: https://ve.scielo.org/scielo.php?script=sci_arttext&pid=S1690-32932016000200003
13. Andres EF, Baidón AG, Cruz EJ, et al. Prevalencia de taeniasis en México durante 2010-2020. Rev Ciencias Farmaceúticas y Biomedicina [Internet]. 2020 [citado 05/10/2023];73. Disponible en: https://rcfb.uanl.mx/index.php/rcfb/article/view/335
14. Vázquez-Rodríguez JM, López-Martínez E, Fleites-Fonticiella L. Neurocisticercosis en mujer adulta joven. Mediciego [Internet]. 2020 [citado 05/10/2023];26(1):e867. Disponible en: https://revmediciego.sld.cu/index.php/mediciego/article/view/867
Downloads
Published
How to Cite
Issue
Section
License
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.